The product, SB623, is being delivered to the damaged region of the brains of people who have suffered an ischemic stroke, which results from an obstruction within a blood vessel supplying blood to the brain. Ischemic strokes account for 87 percent of all stroke cases.
You are here
Coverage of the latest news and updates from the field of stem cells.
The work is important because networks of new blood vessels, assembled in the lab for transplanting into patients, could be a boon to those whose circulatory systems have been damaged by heart disease, diabetes and other illnesses.
He filed his lawsuit in California this week against the Nobel Assembly at Karolinska Institute. Dr. Xu is currently is chairman of MEBO International Group, a private enterprise engaged in life science that he founded in 1987. MEBO has offices in Beijing and in Arcadia, California.
Together the studies could lead to a way to help the heart regeneration itself following a heart attack, and offer new hope for the 17 million people who die from cardiovascular disease each year.
"The effect of these cells has continued for up to two years and has gotten stronger. There was also a major reduction in heart scarring," Bolli told the audience.
In response, Pluristem calls the Bloomberg article “factually inaccurate and misleading.”